Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Arrhythmias

Free Subscription Articles published in Heart Retrieve available abstracts of 119 articles: HTML format

Single Articles

March 2023
1. MOLITOR N, Hofer D, Cimen T, Gasperetti A, et al
   Evolution and triggers of defibrillator shocks in patients with arrhythmogenic right ventricular cardiomyopathy.
   Heart. 2023 Mar 16:heartjnl-2022-321739. doi: 10.1136/heartjnl-2022-321739.
   PubMed     Abstract available
   
   
   
2. FINK T, Sciacca V, Sommer P
   Catheter ablation of atrial fibrillation after percutaneous left atrial appendage closure: friend or foe?
   Heart. 2023 Mar 1:heartjnl-2023-322374. doi: 10.1136/heartjnl-2023-322374.
   PubMed    
   
   
   February 2023
3. SPECTERMAN MJ, Behr ER
   Cardiogenetics: the role of genetic testing for inherited arrhythmia syndromes and sudden death.
   Heart. 2023;109:434-441.
   PubMed     Abstract available
   
   
   
4. BORSCHEL CS, Ortega-Alonso A, Havulinna AS, Jousilahti P, et al
   Inflammatory proteomics profiling for prediction of incident atrial fibrillation.
   Heart. 2023 Feb 17:heartjnl-2022-321959. doi: 10.1136/heartjnl-2022-321959.
   PubMed     Abstract available
   
   
   
5. NADARAJAH R, Wu J, Hogg D, Raveendra K, et al
   Prediction of short-term atrial fibrillation risk using primary care electronic health records.
   Heart. 2023 Feb 9:heartjnl-2022-322076. doi: 10.1136/heartjnl-2022-322076.
   PubMed     Abstract available
   
   
   
6. CHEN JJ, Chiu FC, Chang SN, Cheng HL, et al
   Impact of pre-existing left atrial appendage occluder on catheter ablation of atrial fibrillation.
   Heart. 2023 Feb 7:heartjnl-2022-321934. doi: 10.1136/heartjnl-2022-321934.
   PubMed     Abstract available
   
   
   
7. KIM J, Kim D, Jang E, Kim D, et al
   Associations of high-normal blood pressure and impaired fasting glucose with atrial fibrillation.
   Heart. 2023 Feb 7:heartjnl-2022-322094. doi: 10.1136/heartjnl-2022-322094.
   PubMed     Abstract available
   
   
   January 2023
8. OTTO CM
   Heartbeat: prevention of atrial fibrillation progression.
   Heart. 2023;109:159-161.
   PubMed    
   
   
   
9. JOY M, Williams J, Emanuel S, Kar D, et al
   Trends in direct oral anticoagulant (DOAC) prescribing in English primary care (2014-2019).
   Heart. 2023;109:195-201.
   PubMed     Abstract available
   
   
   
10. LINZ D, Schnabel RB
    Gut microbiota-derived metabolites in atrial fibrillation: risk markers or modifiable risk factors?
    Heart. 2023 Jan 2:heartjnl-2022-321806. doi: 10.1136/heartjnl-2022-321806.
    PubMed    
    
    
    
11. ABDULSALAM NM, Poole JE
    When will we learn? Differential outcomes in women following catheter ablation of atrial fibrillation.
    Heart. 2023 Jan 2:heartjnl-2022-322092. doi: 10.1136/heartjnl-2022-322092.
    PubMed    
    
    
    
12. LUCIANI M, Muller D, Vanetta C, Diteepeng T, et al
    Trimethylamine-N-oxide is associated with cardiovascular mortality and vascular brain lesions in patients with atrial fibrillation.
    Heart. 2023 Jan 2:heartjnl-2022-321300. doi: 10.1136/heartjnl-2022-321300.
    PubMed     Abstract available
    
    
    December 2022
13. PELLEGRINI CN, Buzkova P, Oesterle A, Heckbert SR, et al
    Dysregulated carbohydrate and lipid metabolism and risk of atrial fibrillation in advanced old age.
    Heart. 2022 Dec 22:heartjnl-2022-321633. doi: 10.1136/heartjnl-2022-321633.
    PubMed     Abstract available
    
    
    
14. ARPS K, Piccini JP
    Women, men and the safety gap after catheter ablation of atrial fibrillation.
    Heart. 2022 Dec 22:heartjnl-2022-321632. doi: 10.1136/heartjnl-2022-321632.
    PubMed    
    
    
    
15. LOPEZ-LIZARRAGA MA, Ezquerra-Osorio A, Cueva-Parra A
    Woman with alternating QRS in the emergency department: what is happening?
    Heart. 2022;109:95-158.
    PubMed    
    
    
    
16. BULARGA A, Newby DE, Chapman AR
    Not to be sneezed at: cardiovascular disease after COVID-19 infection.
    Heart. 2022;109:84-85.
    PubMed    
    
    
    November 2022
17. WILKINSON C, Rockwood K
    Frailty assessment in the management of cardiovascular disease.
    Heart. 2022;108:1991-1995.
    PubMed    
    
    
    
18. GUPTA D, Ding WY, Calvert P, Williams E, et al
    Cryoballoon Pulmonary Vein Isolation as First-Line Treatment for Typical Atrial Flutter.
    Heart. 2022 Nov 17. pii: heartjnl-2022-321729. doi: 10.1136/heartjnl-2022-321729
    PubMed     Abstract available
    
    
    
19. WEBER C, Hung J, Hickling S, Li I, et al
    Emergent readmission and long-term mortality risk after incident atrial fibrillation hospitalisation.
    Heart. 2022 Nov 16. pii: heartjnl-2022-321560. doi: 10.1136/heartjnl-2022-321560
    PubMed     Abstract available
    
    
    
20. WALDMANN V, Khairy P
    Atrial fibrillation in Ebstein anomaly: weathering the storm.
    Heart. 2022 Nov 15. pii: heartjnl-2022-321876. doi: 10.1136/heartjnl-2022-321876
    PubMed    
    
    
    
21. MARTIN DE MIGUEL I, Madhavan M, Miranda WR, Connolly HM, et al
    Prognostic implications of atrial fibrillation in adults with Ebstein anomaly.
    Heart. 2022 Nov 11. pii: heartjnl-2022-321493. doi: 10.1136/heartjnl-2022-321493
    PubMed     Abstract available
    
    
    
22. BURSI F, Lee AP
    Strain and mitral regurgitation: is atrial functional mitral regurgitation a ventricular disease?
    Heart. 2022 Nov 11. pii: heartjnl-2022-321945. doi: 10.1136/heartjnl-2022-321945
    PubMed    
    
    
    
23. KITAI T, Nabeta T, Naruse Y, Taniguchi T, et al
    Comparisons between biopsy-proven versus clinically diagnosed cardiac sarcoidosis.
    Heart. 2022;108:1887-1894.
    PubMed     Abstract available
    
    
    
24. AEBERSOLD H, Serra-Burriel M, Foster-Wittassek F, Moschovitis G, et al
    Patient clusters and cost trajectories in the Swiss Atrial Fibrillation cohort.
    Heart. 2022 Nov 4. pii: heartjnl-2022-321520. doi: 10.1136/heartjnl-2022-321520.
    PubMed     Abstract available
    
    
    October 2022
25. CASO V, de Groot JR, Sanmartin Fernandez M, Segura T, et al
    Outcomes and drivers of inappropriate dosing of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a systematic review and meta-analysis.
    Heart. 2022 Oct 31. pii: heartjnl-2022-321114. doi: 10.1136/heartjnl-2022-321114
    PubMed     Abstract available
    
    
    
26. LANE DJ, Grunau B, Kudenchuk P, Dorian P, et al
    Bayesian analysis of amiodarone or lidocaine versus placebo for out-of-hospital cardiac arrest.
    Heart. 2022;108:1777-1783.
    PubMed     Abstract available
    
    
    
27. MEUCCI MC, Stassen J, Tomsic A, Palmen M, et al
    Prognostic impact of left ventricular global longitudinal strain in atrial mitral regurgitation.
    Heart. 2022 Oct 21. pii: heartjnl-2022-321698. doi: 10.1136/heartjnl-2022-321698
    PubMed     Abstract available
    
    
    
28. LYNGBAKKEN MN, Ronningen PS, Solberg MG, Berge T, et al
    Prediction of incident atrial fibrillation with cardiac biomarkers and left atrial volumes.
    Heart. 2022 Oct 19. pii: heartjnl-2022-321608. doi: 10.1136/heartjnl-2022-321608
    PubMed     Abstract available
    
    
    
29. RAMLAKHAN KP, Kauling RM, Schenkelaars N, Segers D, et al
    Supraventricular arrhythmia in pregnancy.
    Heart. 2022;108:1674-1681.
    PubMed     Abstract available
    
    
    September 2022
30. HENDRIKS JM, Elliott AD, Middeldorp ME, Sanders P, et al
    Contributing factors to personalised medicine in atrial fibrillation.
    Heart. 2022 Sep 29. pii: heartjnl-2022-321553. doi: 10.1136/heartjnl-2022-321553
    PubMed    
    
    
    
31. LAWIN D, Lawrenz T, Marx K, Danielsmeier NB, et al
    Gender disparities in alcohol septal ablation for hypertrophic obstructive cardiomyopathy.
    Heart. 2022;108:1623-1628.
    PubMed     Abstract available
    
    
    
32. MSZAR R, Friedman DJ, Ong E, Du C, et al
    Sex-based differences in atrial fibrillation ablation adverse events.
    Heart. 2022 Sep 14. pii: heartjnl-2022-321192. doi: 10.1136/heartjnl-2022-321192
    PubMed     Abstract available
    
    
    
33. MARSCHNER S, von Huben A, Zaman S, Reynolds HR, et al
    Pregnancy-related cardiovascular conditions and outcomes in a United States Medicaid population.
    Heart. 2022;108:1524-1529.
    PubMed     Abstract available
    
    
    August 2022
34. VAN DER VELDEN RMJ, Pluymaekers NAHA, Dudink EAMP, Luermans JGLM, et al
    Mobile health adherence for the detection of recurrent recent-onset atrial fibrillation.
    Heart. 2022 Aug 29. pii: heartjnl-2022-321346. doi: 10.1136/heartjnl-2022-321346
    PubMed     Abstract available
    
    
    
35. SANCHEZ-QUINTANA D, Anderson RH, Tretter JT, Cabrera JA, et al
    Anatomy of the conduction tissues 100 years on: what have we learned?
    Heart. 2022;108:1430-1437.
    PubMed     Abstract available
    
    
    July 2022
36. PARALE C, Velayutham R, Anantharaj A
    Tachycardia in a young man: does pulse oximetry give a clue?
    Heart. 2022;108:1266-1330.
    PubMed    
    
    
    
37. NGUYEN BO, Weberndorfer V, Crijns HJ, Geelhoed B, et al
    Prevalence and determinants of atrial fibrillation progression in paroxysmal atrial fibrillation.
    Heart. 2022 Jul 20. pii: heartjnl-2022-321027. doi: 10.1136/heartjnl-2022-321027
    PubMed     Abstract available
    
    
    
38. VILALTA V, Cediel G, Mohammadi S, Lopez H, et al
    New-onset persistent left bundle branch block following sutureless aortic valve replacement.
    Heart. 2022 Jul 16. pii: heartjnl-2022-321191. doi: 10.1136/heartjnl-2022-321191
    PubMed     Abstract available
    
    
    
39. KANY S, Cardoso VR, Bravo L, Williams JA, et al
    Eligibility for early rhythm control in patients with atrial fibrillation in the UK Biobank.
    Heart. 2022 Jul 14. pii: heartjnl-2022-321196. doi: 10.1136/heartjnl-2022-321196
    PubMed     Abstract available
    
    
    
40. KIM HJ, Chang DH, Kim SO, Kim JK, et al
    Left atrial appendage preservation versus closure during surgical ablation of atrial fibrillation.
    Heart. 2022 Jul 13. pii: heartjnl-2022-320939. doi: 10.1136/heartjnl-2022-320939
    PubMed     Abstract available
    
    
    June 2022
41. MARROQUIN L, Tirado-Conte G, Pracon R, Streb W, et al
    Management and outcomes of patients with left atrial appendage thrombus prior to percutaneous closure.
    Heart. 2022;108:1098-1106.
    PubMed     Abstract available
    
    
    
42. AVILA P, Calvo D, Tamargo M, Uribarri A, et al
    Association of age with clinical features and ablation outcomes of paroxysmal supraventricular tachycardias.
    Heart. 2022;108:1107-1113.
    PubMed     Abstract available
    
    
    
43. TAN HL, Remme CA
    Sudden cardiac death: recognising hidden risk among women versus men.
    Heart. 2022;108:992-993.
    PubMed    
    
    
    May 2022
44. KUDENCHUK PJ
    Management of cardiac arrest in the cardiac catheterisation laboratory: guidelines tailored to place and occasion.
    Heart. 2022;108:907-908.
    PubMed    
    
    
    
45. OTTO CM
    Heartbeat: can cardiogenetics reduce adverse events due to catecholaminergic polymorphic ventricular tachycardia?
    Heart. 2022;108:816-818.
    PubMed    
    
    
    
46. POSTEMA PG, van der Werf C
    Catecholaminergic polymorphic ventricular tachycardia: differences in inheritance and implications for patients, families and future studies.
    Heart. 2022;108:820-821.
    PubMed    
    
    
    
47. SHIMAMOTO K, Ohno S, Kato K, Takayama K, et al
    Impact of cascade screening for catecholaminergic polymorphic ventricular tachycardia type 1.
    Heart. 2022;108:840-847.
    PubMed     Abstract available
    
    
    
48. MARSMAN EMJ, Postema PG, Remme CA
    Brugada syndrome: update and future perspectives.
    Heart. 2022;108:668-675.
    PubMed     Abstract available
    
    
    
49. HAYDOCK P, Camm AJ
    History and evolution of pacing and devices.
    Heart. 2022;108:794-799.
    PubMed     Abstract available
    
    
    April 2022
50. ROSEBOOM E, Maass AH
    Inherited and modifiable factors need to be identified in young patients with atrioventricular block.
    Heart. 2022 Apr 5. pii: heartjnl-2022-320841. doi: 10.1136/heartjnl-2022-320841.
    PubMed    
    
    
    
51. KOMEN J, Pottegard A, Hjemdahl P, Mantel-Teeuwisse AK, et al
    Non-vitamin K antagonist oral anticoagulants, proton pump inhibitors and gastrointestinal bleeds.
    Heart. 2022;108:613-618.
    PubMed     Abstract available
    
    
    
52. MORITA S, Malik AH, Kuno T, Ando T, et al
    Analysis of outcome of 6-month readmissions after percutaneous left atrial appendage occlusion.
    Heart. 2022;108:606-612.
    PubMed     Abstract available
    
    
    
53. HOLT A, Blanche P, Zareini B, Rasmussen PV, et al
    Gastrointestinal bleeding risk following concomitant treatment with oral glucocorticoids in patients on non-vitamin K oral anticoagulants.
    Heart. 2022;108:626-632.
    PubMed     Abstract available
    
    
    
54. HIGUCHI K, Bhargava M
    Management of premature ventricular complexes.
    Heart. 2022;108:565-572.
    PubMed    
    
    
    March 2022
55. PARK YJ, Park JW, Yu HT, Kim TH, et al
    Sex difference in atrial fibrillation recurrence after catheter ablation and antiarrhythmic drugs.
    Heart. 2022 Mar 24. pii: heartjnl-2021-320601. doi: 10.1136/heartjnl-2021-320601
    PubMed     Abstract available
    
    
    
56. RAATIKAINEN P, Lassila R
    COVID-19: another reason for anticoagulation in patients with atrial fibrillation.
    Heart. 2022 Mar 21. pii: heartjnl-2022-320845. doi: 10.1136/heartjnl-2022-320845
    PubMed    
    
    
    
57. GILL S, Bunting KV, Sartini C, Cardoso VR, et al
    Smartphone detection of atrial fibrillation using photoplethysmography: a systematic review and meta-analysis.
    Heart. 2022 Mar 11. pii: heartjnl-2021-320417. doi: 10.1136/heartjnl-2021-320417
    PubMed     Abstract available
    
    
    
58. HANDY A, Banerjee A, Wood AM, Dale C, et al
    Evaluation of antithrombotic use and COVID-19 outcomes in a nationwide atrial fibrillation cohort.
    Heart. 2022 Mar 10. pii: heartjnl-2021-320325. doi: 10.1136/heartjnl-2021-320325
    PubMed     Abstract available
    
    
    
59. DYSSEKILDE JR, Christiansen MK, Johansen JB, Nielsen JC, et al
    Familial risk of atrioventricular block in first-degree relatives.
    Heart. 2022 Mar 4. pii: heartjnl-2021-320411. doi: 10.1136/heartjnl-2021-320411.
    PubMed     Abstract available
    
    
    
60. FRANKE KB, Mahajan R
    Cardiac oxidative stress: a potential tool for risk stratification in cardiac sarcoidosis.
    Heart. 2022;108:410-411.
    PubMed    
    
    
    
61. YOSHITOMI R, Kobayashi S, Yano Y, Nakashima Y, et al
    Enhanced oxidative stress and presence of ventricular aneurysm for risk prediction in cardiac sarcoidosis.
    Heart. 2022;108:429-437.
    PubMed     Abstract available
    
    
    February 2022
62. EVERS-DORPFELD S, Aeschbacher S, Hennings E, Eken C, et al
    Sex-specific differences in adverse outcome events among patients with atrial fibrillation.
    Heart. 2022 Feb 8. pii: heartjnl-2021-320122. doi: 10.1136/heartjnl-2021-320122.
    PubMed     Abstract available
    
    
    
63. OTTO CM
    Heartbeat: bleeding risk in atrial fibrillation patients on non-vitamin K oral anticoagulant medications.
    Heart. 2022;108:243-245.
    PubMed    
    
    
    
64. GUPTA A, Arora GK, Isser HS
    An elderly woman with recurrent syncope.
    Heart. 2022;108:257-324.
    PubMed    
    
    
    
65. MORRONE D, De Caterina R
    Bleeding risk score: limits and practicability.
    Heart. 2022;108:246-248.
    PubMed    
    
    
    January 2022
66. TUTAREL O, Baris L, Budts W, Gamal Abd-El Aziz M, et al
    Pregnancy outcomes in women with a systemic right ventricle and transposition of the great arteries results from the ESC-EORP Registry of Pregnancy and Cardiac disease (ROPAC).
    Heart. 2022;108:117-123.
    PubMed     Abstract available
    
    
    
67. VITALE G, Ditaranto R, Graziani F, Tanini I, et al
    Standard ECG for differential diagnosis between Anderson-Fabry disease and hypertrophic cardiomyopathy.
    Heart. 2022;108:54-60.
    PubMed     Abstract available
    
    
    December 2021
68. OTTO CM
    Heartbeat: lower risk of dementia with a direct oral anticoagulatant, compared to a vitamin K antagonist, for patients with atrial fibrillation.
    Heart. 2021;107:1847-1849.
    PubMed    
    
    
    
69. DING WY, Mahida S
    Wide complex tachycardia: differentiating ventricular tachycardia from supraventricular tachycardia.
    Heart. 2021;107:1995-2003.
    PubMed    
    
    
    November 2021
70. OTTO CM
    Heartbeat: ECG approaches to early detection of atrial fibrillation.
    Heart. 2021;107:1765-1767.
    PubMed    
    
    
    October 2021
71. HIMELFARB JD, Shulman H, Olesovsky CJ, Rumman RK, et al
    Atrial fibrillation following transcatheter atrial septal defect closure: a systematic review and meta-analysis.
    Heart. 2021 Oct 21. pii: heartjnl-2021-319794. doi: 10.1136/heartjnl-2021-319794
    PubMed     Abstract available
    
    
    
72. DEYELL MW, Hawkins NM
    Odd couple: premature ventricular contractions and heart failure.
    Heart. 2021 Oct 19. pii: heartjnl-2021-319986. doi: 10.1136/heartjnl-2021-319986
    PubMed    
    
    
    
73. CADOGAN SL, Powell E, Wing K, Wong AY, et al
    Anticoagulant prescribing for atrial fibrillation and risk of incident dementia.
    Heart. 2021 Oct 13. pii: heartjnl-2021-319672. doi: 10.1136/heartjnl-2021-319672
    PubMed     Abstract available
    
    
    
74. CHUA W
    Clearing the cognitive cloud: direct oral anticoagulants or vitamin K antagonists for reducing dementia risk in patients with atrial fibrillation?
    Heart. 2021 Oct 13. pii: heartjnl-2021-320138. doi: 10.1136/heartjnl-2021-320138
    PubMed    
    
    
    
75. NADARAJAH R, Alsaeed E, Hurdus B, Aktaa S, et al
    Prediction of incident atrial fibrillation in community-based electronic health records: a systematic review with meta-analysis.
    Heart. 2021 Oct 4. pii: heartjnl-2021-320036. doi: 10.1136/heartjnl-2021-320036.
    PubMed     Abstract available
    
    
    
76. ZAMAN J, Agarwal S
    Management of ventricular tachycardia storm.
    Heart. 2021;107:1671-1677.
    PubMed    
    
    
    September 2021
77. BARNETT-GRINESS O, Stein N, Kotler A, Saliba W, et al
    Novel bleeding prediction model in atrial fibrillation patients on new oral anticoagulants.
    Heart. 2021 Sep 21. pii: heartjnl-2021-319702. doi: 10.1136/heartjnl-2021-319702
    PubMed     Abstract available
    
    
    
78. KASHOU A, Noseworthy P
    Predicting incident atrial fibrillation in sinus rhythm: more than just trusting the 'black box'.
    Heart. 2021 Sep 7. pii: heartjnl-2021-319385. doi: 10.1136/heartjnl-2021-319385.
    PubMed    
    
    
    
79. LIMPITIKUL WB, Dewland TA, Vittinghoff E, Soliman E, et al
    Premature ventricular complexes and development of heart failure in a community-based population.
    Heart. 2021 Sep 7. pii: heartjnl-2021-319473. doi: 10.1136/heartjnl-2021-319473.
    PubMed     Abstract available
    
    
    
80. NASER JA, Pislaru S, Stan MN, Lin G, et al
    Incidence, risk factors, natural history and outcomes of heart failure in patients with Graves' disease.
    Heart. 2021 Sep 6. pii: heartjnl-2021-319752. doi: 10.1136/heartjnl-2021-319752.
    PubMed     Abstract available
    
    
    August 2021
81. BLAAUW Y, Mulder B, Rienstra M
    Is catheter ablation of atrial fibrillation as first-line treatment ready for prime time?
    Heart. 2021 Aug 12. pii: heartjnl-2021-319832. doi: 10.1136/heartjnl-2021-319832
    PubMed    
    
    
    
82. KANY S, Schnabel R
    Adding to the evidence or to the confusion: dual antithrombotic therapy in chronic coronary syndrome and atrial fibrillation.
    Heart. 2021 Aug 12. pii: heartjnl-2021-319830. doi: 10.1136/heartjnl-2021-319830
    PubMed    
    
    
    
83. SCHNABEL RB, Wallenhorst C, Engler D, Blankenberg S, et al
    Refined atrial fibrillation screening and cost-effectiveness in the German population.
    Heart. 2021 Aug 10. pii: heartjnl-2020-318882. doi: 10.1136/heartjnl-2020-318882
    PubMed     Abstract available
    
    
    
84. TOOLEY JE, Perez MV
    Role of digital health in detection and management of atrial fibrillation.
    Heart. 2021 Aug 3. pii: heartjnl-2020-318262. doi: 10.1136/heartjnl-2020-318262.
    PubMed     Abstract available
    
    
    
85. OTTO CM
    Heartbeat: improved quality of life and reduced healthcare utilisation after catheter ablation in patients with drug-resistant paroxysmal atrial fibrillation.
    Heart. 2021;107:1271-1273.
    PubMed    
    
    
    July 2021
86. FUKAYA H, Ako J, Yasuda S, Kaikita K, et al
    Aspirin versus P2Y12 inhibitors with anticoagulation therapy for atrial fibrillation.
    Heart. 2021 Jul 14. pii: heartjnl-2021-319321. doi: 10.1136/heartjnl-2021-319321
    PubMed     Abstract available
    
    
    
87. IMBERTI JF, Ding WY, Kotalczyk A, Zhang J, et al
    Catheter ablation as first-line treatment for paroxysmal atrial fibrillation: a systematic review and meta-analysis.
    Heart. 2021 Jul 14. pii: heartjnl-2021-319496. doi: 10.1136/heartjnl-2021-319496
    PubMed     Abstract available
    
    
    
88. PHILLIPS K, Subramanian A, Thomas GN, Khan N, et al
    Trends in the pharmacological management of atrial fibrillation in UK general practice 2008-2018.
    Heart. 2021 Jul 5. pii: heartjnl-2021-319338. doi: 10.1136/heartjnl-2021-319338.
    PubMed     Abstract available
    
    
    June 2021
89. CHEN TH, Chu YC, Ou SM, Tarng DC, et al
    Associations of atrial fibrillation with renal function decline in patients with chronic kidney disease.
    Heart. 2021 Jun 30. pii: heartjnl-2021-319297. doi: 10.1136/heartjnl-2021-319297
    PubMed     Abstract available
    
    
    
90. MULDER BA, Rienstra M, Van Gelder IC, Blaauw Y, et al
    Update on management of atrial fibrillation in heart failure: a focus on ablation.
    Heart. 2021 Jun 4. pii: heartjnl-2020-318081. doi: 10.1136/heartjnl-2020-318081.
    PubMed     Abstract available
    
    
    
91. SANZ-GARCIA A, Cecconi A, Vera A, Camarasaltas JM, et al
    Electrocardiographic biomarkers to predict atrial fibrillation in sinus rhythm electrocardiograms.
    Heart. 2021 Jun 4. pii: heartjnl-2021-319120. doi: 10.1136/heartjnl-2021-319120.
    PubMed     Abstract available
    
    
    
92. MINNERS J, Jander N
    Consecutive, index and representative beats: obtaining reliable information despite an irregular heart rhythm.
    Heart. 2021;107:862-863.
    PubMed    
    
    
    
93. BRIGNOLE M, Rivasi G
    New insights in diagnostics and therapies in syncope: a novel approach to non-cardiac syncope.
    Heart. 2021;107:864-873.
    PubMed     Abstract available
    
    
    
94. PARKER WA, Storey RF
    Antithrombotic therapy for patients with chronic coronary syndromes.
    Heart. 2021;107:925-933.
    PubMed    
    
    
    May 2021
95. WILDE AAM, Amin AS, Postema PG
    Diagnosis, management and therapeutic strategies for congenital long QT syndrome.
    Heart. 2021 May 26. pii: heartjnl-2020-318259. doi: 10.1136/heartjnl-2020-318259
    PubMed     Abstract available
    
    
    
96. KAWAJI T, Ogawa H, Hamatani Y, Kato M, et al
    Association of inverted T wave during atrial fibrillation rhythm with subsequent cardiac events.
    Heart. 2021 May 26. pii: heartjnl-2021-319199. doi: 10.1136/heartjnl-2021-319199
    PubMed     Abstract available
    
    
    
97. NICOLI CD, O'Neal WT, Levitan EB, Singleton MJ, et al
    Atrial fibrillation and risk of incident heart failure with reduced versus preserved ejection fraction.
    Heart. 2021 May 24. pii: heartjnl-2021-319122. doi: 10.1136/heartjnl-2021-319122
    PubMed     Abstract available
    
    
    
98. ROSSIDES M, Kullberg S, Grunewald J, Eklund A, et al
    Risk and predictors of heart failure in sarcoidosis in a population-based cohort study from Sweden.
    Heart. 2021 May 21. pii: heartjnl-2021-319129. doi: 10.1136/heartjnl-2021-319129
    PubMed     Abstract available
    
    
    
99. ELVAN A
    It's all about improvement of quality of life and reduction of disease burden in atrial fibrillation ablation.
    Heart. 2021 May 20. pii: heartjnl-2021-319382. doi: 10.1136/heartjnl-2021-319382
    PubMed    
    
    
    
100. BOSMAN LP, Te Riele ASJM
     Arrhythmogenic right ventricular cardiomyopathy: a focused update on diagnosis and risk stratification.
     Heart. 2021 May 14. pii: heartjnl-2021-319113. doi: 10.1136/heartjnl-2021-319113
     PubMed     Abstract available
     
     
     
101. CHOI Y, Lee Y, Kim SH, Kim S, et al
     Single direct oral anticoagulant therapy in stable patients with atrial fibrillation beyond 1 year after coronary stent implantation.
     Heart. 2021 May 14. pii: heartjnl-2020-318750. doi: 10.1136/heartjnl-2020-318750
     PubMed     Abstract available
     
     
     
102. GUPTA D, Ding WY
     Contemporary management of persistent atrial fibrillation.
     Heart. 2021 May 14. pii: heartjnl-2020-317422. doi: 10.1136/heartjnl-2020-317422
     PubMed    
     
     
     
103. CHUA W, Fabritz L
     Heart failure in patients with atrial fibrillation: why it matters now more than ever.
     Heart. 2021 May 13. pii: heartjnl-2021-319145. doi: 10.1136/heartjnl-2021-319145
     PubMed    
     
     
     
104. RUTHERFORD OW, Jonasson C, Ghanima W, Soderdahl F, et al
     Effectiveness and safety of oral anticoagulants in elderly patients with atrial fibrillation.
     Heart. 2021 May 11. pii: heartjnl-2020-318753. doi: 10.1136/heartjnl-2020-318753
     PubMed     Abstract available
     
     
     
105. GUPTA D, Vijgen J, Potter T, Scherr D, et al
     Quality of life and healthcare utilisation improvements after atrial fibrillation ablation.
     Heart. 2021 May 5. pii: heartjnl-2020-318676. doi: 10.1136/heartjnl-2020-318676.
     PubMed     Abstract available
     
     
     
106. JOLOBE O
     Next frontier is inclusion of high-grade carotid artery stenosis in the CHA2DS2 Vasc score.
     Heart. 2021;107:767.
     PubMed    
     
     
     
107. KARTHIKEYAN G
     Stroke risk in rheumatic heart disease.
     Heart. 2021;107:694-696.
     PubMed    
     
     
     
108. FAN P, Zhang Y, Lu YT, Yang KQ, et al
     Prognostic value of plasma big endothelin-1 in left ventricular non-compaction cardiomyopathy.
     Heart. 2021;107:836-841.
     PubMed     Abstract available
     
     
     April 2021
109. SANTOS IS, Bensenor IM
     Cardiovascular health and atrial fibrillation.
     Heart. 2021 Apr 15. pii: heartjnl-2021-319253. doi: 10.1136/heartjnl-2021-319253
     PubMed    
     
     
     
110. LEE JH, Yang PS, Yu HT, Kim TH, et al
     Association of cardiovascular health and incident atrial fibrillation in elderly population.
     Heart. 2021 Apr 2. pii: heartjnl-2020-318858. doi: 10.1136/heartjnl-2020-318858.
     PubMed     Abstract available
     
     
     
111. YEO C, Wang Y, Tan VH
     Wide complex tachycardia captured on smartwatch.
     Heart. 2021;107:626-684.
     PubMed    
     
     
     
112. GEURINK K, Holmes D, Ezekowitz MD, Pieper K, et al
     Patterns of oral anticoagulation use with cardioversion in clinical practice.
     Heart. 2021;107:642-649.
     PubMed     Abstract available
     
     
     
113. SPARROW R, Sanjoy S, Choi YH, Elgendy IY, et al
     Racial, ethnic and socioeconomic disparities in patients undergoing left atrial appendage closure.
     Heart. 2021 Apr 1. pii: heartjnl-2020-318650. doi: 10.1136/heartjnl-2020-318650.
     PubMed     Abstract available
     
     
     February 2021
114. SINNING CR
     Biomarkers for detection of a thrombus in the left atrial appendage: the search for the grail?
     Heart. 2021;107:176-177.
     PubMed    
     
     
     January 2021
115. SINGH T, Newby DE
     Is the fear of disease worse than the disease itself?
     Heart. 2021;107:91-92.
     PubMed    
     
     
     October 2020
116. MULDER BA, Rienstra M, Blaauw Y
     Evaluation and treatment of premature ventricular contractions in heart failure with reduced ejection fraction.
     Heart. 2020 Oct 19. pii: heartjnl-2020-317491. doi: 10.1136/heartjnl-2020-317491
     PubMed     Abstract available
     
     
     September 2020
117. IHSAN J, Khand A, Adlan AM
     Ventricular storm following late presentation acute myocardial infarction.
     Heart. 2020;106:1399-1448.
     PubMed    
     
     
     May 2020
118. KIM WK, Kim HJ, Kim JB, Jung SH, et al
     Exclusion versus preservation of the left atrial appendage in rheumatic mitral valve surgery.
     Heart. 2020 May 6. pii: heartjnl-2019-316387. doi: 10.1136/heartjnl-2019-316387.
     PubMed     Abstract available
     
     
     January 2020
119. TAN TC, Nunes MCP, Handschumacher M, Pontes-Neto O, et al
     Left atrial cross-sectional area is a novel measure of atrial shape associated with cardioembolic strokes.
     Heart. 2020 Jan 24. pii: heartjnl-2019-315964. doi: 10.1136/heartjnl-2019-315964
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Arrhythmias is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: